Virpax Pharmaceuticals, Inc. (VRPX) Misses Q3 EPS by 25c
Tweet
Share
E-mailGet Alerts VRPX Hot Sheet
Join SI Premium – FREE
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) reported Q3 EPS of ($0.51), $0.25 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Virpax Pharmaceuticals, Inc. (VRPX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- RBC Capital Starts Molina Healthcare (MOH) at Sector Perform
- NVE Corporation names new CEO and expands board to seven members
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
